FDA Drug Application (204026) for POMALYST by CELGENE

Back to FDA Applications sponsored by CELGENE

Application Number204026
Product Number001
FormCAPSULE;ORAL
Dosage1MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NamePOMALYST
Active IngredientPOMALIDOMIDE



Back to FDA Applications sponsored by CELGENE

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.